2020
DOI: 10.1002/ccr3.2718
|View full text |Cite
|
Sign up to set email alerts
|

Adenocarcinoma of intestinal type arising in mature cystic teratoma of ovary: A diagnostic dilemma

Abstract: Adenocarcinomas of intestinal type arising in mature cystic teratoma of ovary (MCT) are extremely rare and remain a diagnostic dilemma because of its similarities with MCT. Serum tumor markers CEA and SCC and also MRI may help in the preoperative diagnosis. Pathologist experience helps in intraoperative diagnosis.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(4 citation statements)
references
References 12 publications
0
4
0
Order By: Relevance
“…Therefore, it should not be considered merely an ovarian tumor. The incidence of mature teratoma with malignant transformation is less than 2%[ 4 , 5 ], the most common type of malignant transformation is squamous cell carcinoma, which exceeds 80%, followed by adenocarcinoma[ 6 , 7 ]. Colorectal primary mature teratoma is extremely rare, most of which is reported as individual cases, and mostly in the rectum.…”
Section: Discussionmentioning
confidence: 99%
“…Therefore, it should not be considered merely an ovarian tumor. The incidence of mature teratoma with malignant transformation is less than 2%[ 4 , 5 ], the most common type of malignant transformation is squamous cell carcinoma, which exceeds 80%, followed by adenocarcinoma[ 6 , 7 ]. Colorectal primary mature teratoma is extremely rare, most of which is reported as individual cases, and mostly in the rectum.…”
Section: Discussionmentioning
confidence: 99%
“…Squamous cell carcinoma is the most common type [ 16 , 21 ]. Other less frequent malignant transformations include mucinous carcinoma [ 21 ], adenocarcinoma [ 22 , 23 , 24 , 25 , 26 ], melanoma [ 27 ], carcinoid [ 28 , 29 , 30 ], oligodendroglioma [ 31 , 32 , 33 ], and sarcoma [ 34 , 35 , 36 , 37 ].…”
Section: Epidemiologymentioning
confidence: 99%
“…Alkylating drugs were also found to be associated with significant increases in survival in tumors at stages beyond Ia in Hackethal’s study in 2008 [ 16 ]. Paclitaxel and carboplatin are used in patients with adenocarcinoma [ 22 ]. Dacarbazine (DTIC) monotherapy or combination therapy, including nitrosourea and cisplatin, may be administered as adjuvant therapies for patients with melanoma [ 27 ].…”
Section: Treatmentmentioning
confidence: 99%
See 1 more Smart Citation